In a filing, Relmada Therapeutics Inc revealed its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $86735.0 on Aug 27 ’25. In the deal valued at $0.67 per share,129,455 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 944,024 shares worth roughly $1.34 million.
Then, TRAVERSA SERGIO bought 80,545 shares, generating $49,938 in total proceeds. Upon buying the shares at $0.62, the Chief Executive Officer now owns 814,569 shares.
Before that, TRAVERSA SERGIO bought 55,976 shares. Relmada Therapeutics Inc shares valued at $41,422 were divested by the Chief Executive Officer at a price of $0.74 per share. As a result of the transaction, TRAVERSA SERGIO now holds 1,000,000 shares, worth roughly $1.42 million.
Mizuho downgraded its Relmada Therapeutics Inc [RLMD] rating to a Neutral from a an Outperform in a research note published on December 05, 2024; the price target was decreased to $1 from $23. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in mid September from “a Hold” to “a Buy”. Goldman also remained covering RLMD and has decreased its forecast on June 05, 2024 with a “Sell” recommendation from previously “Neutral” rating. Truist revised its rating on October 14, 2022. It rated RLMD as “a Hold” which previously was an “a Buy”.
Price Performance Review of RLMD
On Tuesday, Relmada Therapeutics Inc [NASDAQ:RLMD] saw its stock jump 26.79% to $1.42. Over the last five days, the stock has gained 127.56%. Relmada Therapeutics Inc shares have fallen nearly -45.17% since the year began. Nevertheless, the stocks have risen 173.08% over the past one year. While a 52-week high of $3.98 was reached on 09/02/25, a 52-week low of $0.24 was recorded on 03/03/25.
Levels Of Support And Resistance For RLMD Stock
The 24-hour chart illustrates a support level at 1.1305, which if violated will result in even more drops to 0.8411. On the upside, there is a resistance level at 1.6389. A further resistance level may holdings at 1.8579.
How much short interest is there in Relmada Therapeutics Inc?
A steep rise in short interest was recorded in Relmada Therapeutics Inc stocks on 2025-08-15, growing by 54481.0 shares to a total of 0.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 0.42 million shares. There was a rise of 11.39%, which implies that there is a positive sentiment for the stock.
